ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹5.23 Cr | ₹52 Cr | ₹96 Cr | ₹269 Cr | ₹-90 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ASTRAZENECA PHARMA INDIA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹5.23 Cr |
Mar2023 | ₹52 Cr |
Mar2022 | ₹96 Cr |
Mar2021 | ₹269 Cr |
Mar2020 | ₹-90 Cr |
How is Net Cash Inflow / Outflow of ASTRAZENECA PHARMA INDIA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹5.23 Cr | -89.93 | |
Mar2023 | ₹52 Cr | -45.96 | |
Mar2022 | ₹96 Cr | -64.26 | |
Mar2021 | ₹269 Cr | Positive | |
Mar2020 | ₹-90 Cr | - |
Compare Net Cash Inflow / Outflow of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹17,418.5 Cr | 2.5% | 7.7% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 2.5% |
7.7% |
7.5% |
SENSEX | -0.4% |
-2.1% |
6.9% |
You may also like the below Video Courses